Showing 1–7 of 7 results for author: Galtier, M

Industry-Scale Orchestrated Federated Learning for Drug Discovery

Authors: Martijn Oldenhof, Gergely Ács, Balázs Pejó, Ansgar Schuffenhauer, Nicholas Holway, Noé Sturm, Arne Dieckmann, Oliver Fortmeier, Eric Boniface, Clément Mayer, Arnaud Gohier, Peter Schmidtke, Ritsuya Niwayama, Dieter Kopecky, Lewis Mervin, Prakash Chandra Rathi, Lukas Friedrich, András Formanek, Peter Antal, Jordon Rahaman, Adam Zalewski, Wouter Heyndrickx, Ezron Oluoch, Manuel Stößel, Michal Vančo , et al. (22 additional authors not shown)

Abstract: To apply federated learning to drug discovery we developed a novel platform in the context of European Innovative Medicines Initiative (IMI) project MELLODDY (grant n°831472), which was comprised of 10 pharmaceutical companies, academic research labs, large industrial companies and startups. The MELLODDY platform was the first industry-scale platform to enable the creation of a global federated mo… ▽ More To apply federated learning to drug discovery we developed a novel platform in the context of European Innovative Medicines Initiative (IMI) project MELLODDY (grant n°831472), which was comprised of 10 pharmaceutical companies, academic research labs, large industrial companies and startups. The MELLODDY platform was the first industry-scale platform to enable the creation of a global federated model for drug discovery without sharing the confidential data sets of the individual partners. The federated model was trained on the platform by aggregating the gradients of all contributing partners in a cryptographic, secure way following each training iteration. The platform was deployed on an Amazon Web Services (AWS) multi-account architecture running Kubernetes clusters in private subnets. Organisationally, the roles of the different partners were codified as different rights and permissions on the platform and administrated in a decentralized way. The MELLODDY platform generated new scientific discoveries which are described in a companion paper. △ Less

Submitted 12 December, 2022; v1 submitted 17 October, 2022; originally announced October 2022.

Comments: 9 pages, 4 figures, to appear in AAAI-23 ([IAAI-23 track] Deployed Highly Innovative Applications of AI)

Collaborative Drug Discovery: Inference-level Data Protection Perspective

Authors: Balazs Pejo, Mina Remeli, Adam Arany, Mathieu Galtier, Gergely Acs

Abstract: Pharmaceutical industry can better leverage its data assets to virtualize drug discovery through a collaborative machine learning platform. On the other hand, there are non-negligible risks stemming from the unintended leakage of participants' training data, hence, it is essential for such a platform to be secure and privacy-preserving. This paper describes a privacy risk assessment for collaborat… ▽ More Pharmaceutical industry can better leverage its data assets to virtualize drug discovery through a collaborative machine learning platform. On the other hand, there are non-negligible risks stemming from the unintended leakage of participants' training data, hence, it is essential for such a platform to be secure and privacy-preserving. This paper describes a privacy risk assessment for collaborative modeling in the preclinical phase of drug discovery to accelerate the selection of promising drug candidates. After a short taxonomy of state-of-the-art inference attacks we adopt and customize several to the underlying scenario. Finally we describe and experiments with a handful of relevant privacy protection techniques to mitigate such attacks. △ Less

Submitted 9 June, 2022; v1 submitted 13 May, 2022; originally announced May 2022.

The Future of Digital Health with Federated Learning

Authors: Nicola Rieke, Jonny Hancox, Wenqi Li, Fausto Milletari, Holger Roth, Shadi Albarqouni, Spyridon Bakas, Mathieu N. Galtier, Bennett Landman, Klaus Maier-Hein, Sebastien Ourselin, Micah Sheller, Ronald M. Summers, Andrew Trask, Daguang Xu, Maximilian Baust, M. Jorge Cardoso

Abstract: Data-driven Machine Learning has emerged as a promising approach for building accurate and robust statistical models from medical data, which is collected in huge volumes by modern healthcare systems. Existing medical data is not fully exploited by ML primarily because it sits in data silos and privacy concerns restrict access to this data. However, without access to sufficient data, ML will be pr… ▽ More Data-driven Machine Learning has emerged as a promising approach for building accurate and robust statistical models from medical data, which is collected in huge volumes by modern healthcare systems. Existing medical data is not fully exploited by ML primarily because it sits in data silos and privacy concerns restrict access to this data. However, without access to sufficient data, ML will be prevented from reaching its full potential and, ultimately, from making the transition from research to clinical practice. This paper considers key factors contributing to this issue, explores how Federated Learning (FL) may provide a solution for the future of digital health and highlights the challenges and considerations that need to be addressed. △ Less

Submitted 15 January, 2021; v1 submitted 18 March, 2020; originally announced March 2020.

Comments: This is a pre-print version of https://www.nature.com/articles/s41746-020-00323-1

Journal ref: npj Digital Medicine volume 3, Article number: 119 (2020)

Substra: a framework for privacy-preserving, traceable and collaborative Machine Learning

Authors: Mathieu N Galtier, Camille Marini

Abstract: Machine learning is promising, but it often needs to process vast amounts of sensitive data which raises concerns about privacy. In this white-paper, we introduce Substra, a distributed framework for privacy-preserving, traceable and collaborative Machine Learning. Substra gathers data providers and algorithm designers into a network of nodes that can train models on demand but under advanced perm… ▽ More Machine learning is promising, but it often needs to process vast amounts of sensitive data which raises concerns about privacy. In this white-paper, we introduce Substra, a distributed framework for privacy-preserving, traceable and collaborative Machine Learning. Substra gathers data providers and algorithm designers into a network of nodes that can train models on demand but under advanced permission regimes. To guarantee data privacy, Substra implements distributed learning: the data never leave their nodes; only algorithms, predictive models and non-sensitive metadata are exchanged on the network. The computations are orchestrated by a Distributed Ledger Technology which guarantees traceability and authenticity of information without needing to trust a third party. Although originally developed for Healthcare applications, Substra is not data, algorithm or programming language specific. It supports many types of computation plans including parallel computation plan commonly used in Federated Learning. With appropriate guidelines, it can be deployed for numerous Machine Learning use-cases with data or algorithm providers where trust is limited. △ Less

Submitted 25 October, 2019; originally announced October 2019.

A deep learning architecture for temporal sleep stage classification using multivariate and multimodal time series

Authors: Stanislas Chambon, Mathieu Galtier, Pierrick Arnal, Gilles Wainrib, Alexandre Gramfort

Abstract: Sleep stage classification constitutes an important preliminary exam in the diagnosis of sleep disorders. It is traditionally performed by a sleep expert who assigns to each 30s of signal a sleep stage, based on the visual inspection of signals such as electroencephalograms (EEG), electrooculograms (EOG), electrocardiograms (ECG) and electromyograms (EMG). We introduce here the first deep learning… ▽ More Sleep stage classification constitutes an important preliminary exam in the diagnosis of sleep disorders. It is traditionally performed by a sleep expert who assigns to each 30s of signal a sleep stage, based on the visual inspection of signals such as electroencephalograms (EEG), electrooculograms (EOG), electrocardiograms (ECG) and electromyograms (EMG). We introduce here the first deep learning approach for sleep stage classification that learns end-to-end without computing spectrograms or extracting hand-crafted features, that exploits all multivariate and multimodal Polysomnography (PSG) signals (EEG, EMG and EOG), and that can exploit the temporal context of each 30s window of data. For each modality the first layer learns linear spatial filters that exploit the array of sensors to increase the signal-to-noise ratio, and the last layer feeds the learnt representation to a softmax classifier. Our model is compared to alternative automatic approaches based on convolutional networks or decisions trees. Results obtained on 61 publicly available PSG records with up to 20 EEG channels demonstrate that our network architecture yields state-of-the-art performance. Our study reveals a number of insights on the spatio-temporal distribution of the signal of interest: a good trade-off for optimal classification performance measured with balanced accuracy is to use 6 EEG with 2 EOG (left and right) and 3 EMG chin channels. Also exploiting one minute of data before and after each data segment offers the strongest improvement when a limited number of channels is available. As sleep experts, our system exploits the multivariate and multimodal nature of PSG signals in order to deliver state-of-the-art classification performance with a small computational cost. △ Less

Submitted 27 November, 2017; v1 submitted 5 July, 2017; originally announced July 2017.

Morpheo: Traceable Machine Learning on Hidden data

Authors: Mathieu Galtier, Camille Marini

Abstract: Morpheo is a transparent and secure machine learning platform collecting and analysing large datasets. It aims at building state-of-the art prediction models in various fields where data are sensitive. Indeed, it offers strong privacy of data and algorithm, by preventing anyone to read the data, apart from the owner and the chosen algorithms. Computations in Morpheo are orchestrated by a blockchai… ▽ More Morpheo is a transparent and secure machine learning platform collecting and analysing large datasets. It aims at building state-of-the art prediction models in various fields where data are sensitive. Indeed, it offers strong privacy of data and algorithm, by preventing anyone to read the data, apart from the owner and the chosen algorithms. Computations in Morpheo are orchestrated by a blockchain infrastructure, thus offering total traceability of operations. Morpheo aims at building an attractive economic ecosystem around data prediction by channelling crypto-money from prediction requests to useful data and algorithms providers. Morpheo is designed to handle multiple data sources in a transfer learning approach in order to mutualize knowledge acquired from large datasets for applications with smaller but similar datasets. △ Less

Submitted 17 April, 2017; originally announced April 2017.

Comments: whitepaper, 9 pages, 6 figures

A biological gradient descent for prediction through a combination of STDP and homeostatic plasticity

Authors: Mathieu Galtier, Gilles Wainrib

Abstract: Identifying, formalizing and combining biological mechanisms which implement known brain functions, such as prediction, is a main aspect of current research in theoretical neuroscience. In this letter, the mechanisms of Spike Timing Dependent Plasticity (STDP) and homeostatic plasticity, combined in an original mathematical formalism, are shown to shape recurrent neural networks into predictors. F… ▽ More Identifying, formalizing and combining biological mechanisms which implement known brain functions, such as prediction, is a main aspect of current research in theoretical neuroscience. In this letter, the mechanisms of Spike Timing Dependent Plasticity (STDP) and homeostatic plasticity, combined in an original mathematical formalism, are shown to shape recurrent neural networks into predictors. Following a rigorous mathematical treatment, we prove that they implement the online gradient descent of a distance between the network activity and its stimuli. The convergence to an equilibrium, where the network can spontaneously reproduce or predict its stimuli, does not suffer from bifurcation issues usually encountered in learning in recurrent neural networks. △ Less

Submitted 11 June, 2013; v1 submitted 21 June, 2012; originally announced June 2012.

Comments: 36 pages, 3 figures